Is Medico Remedies the Best Stock in Its Sector? A Look at the Numbers

Medico Remedies CMP Rs 22 (01 Oct 2026). Market cap Rs 179 Cr. ROE 17.38%. P/E 13.00x versus Industry P/E 51.55x.

Is Medico Remedies the best stock in its sector? The stock trades on the NSE at Rs 22 as of 01 October 2026, within its 52-week range of Rs 20.47 to Rs 56.88. Medico Remedies Ltd manufactures pharmaceutical formulations.

Medico Remedies sits in the Healthcare sector, and its 17.38% ROE and 13.00x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Click Here – Get Free Investment Predictions

About Medico Remedies

Medico Remedies Ltd manufactures pharmaceutical formulations. The stock rose nearly 2.5 percent during this session, and its thin book value per share means ratios should be treated with some caution. At a market capitalisation of Rs 179 Cr, it is tracked as part of the Healthcare sector on Univest.

Is Medico Remedies the Best Stock in Its Sector?

Medico Remedies makes its case as the best stock in its sector primarily on return on equity and balance sheet strength, combining a 17.38% ROE with a 13.00x P/E against the sector’s 51.55x Industry P/E. Medico Remedies’ 13.00x P/E is far below the 51.55x Industry P/E despite a strong 17.38% ROE, though a thin book value per share means the ratios should be read with some caution.

Metric	Medico Remedies
CMP (NSE)	Rs 22.06
52-Week High / Low	Rs 56.88 / Rs 20.47
Market Cap	Rs 179 Cr
P/E (TTM) vs Industry P/E	13.00x vs 51.55x
P/B	2.37
ROE	17.38%
EPS (TTM)	Rs 1.66
Dividend Yield	0.00%
Debt to Equity	0.25

Compare Medico Remedies Against Other Healthcare Sector Stocks

How Medico Remedies Compares Against Its Healthcare Sector Peers

The table below sets Medico Remedies against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.

Company	Market Cap (Rs Cr)	P/E	ROE	Debt to Equity
Medico Remedies	179	13.00	17.38%	0.25
Kilitch Drugs India	771	26.41	10.79%	0.32
Lincoln Pharmaceuticals	1,172	12.15	11.60%	0.01
Peer average (2 companies)	–	19.28	11.20%	0.17

Against this peer set, Medico Remedies’s 17.38% ROE is above the 11.20% peer average, and its P/E of 13.00x runs below the peer average of 19.28x. Medico Remedies’ 13.00x P/E is far below the 51.55x Industry P/E despite a strong 17.38% ROE, though a thin book value per share means the ratios should be read with some caution.

What Makes Medico Remedies Worth Watching in Healthcare

• Well below Industry P/E: A 13.00x P/E against a 51.55x Industry P/E is a wide discount for a business with a strong 17.38% ROE.
• Strong ROE: A 17.38% ROE is well above most Healthcare peers covered in this series.
• Moderate leverage: A debt to equity ratio of 0.25 is manageable for a pharma manufacturer.

Medico Remedies Valuation: Is It Justified?

Medico Remedies’ 13.00x P/E is far below the 51.55x Industry P/E despite a strong 17.38% ROE, though a thin book value per share means the ratios should be read with some caution. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.

Also read – Is Mayur Uniquoters the Best Stock in Its Sector? A Look at the Numbers

Download the Univest iOS App or Univest Android App to track Medico Remedies and other Healthcare sector stocks.

How to Track Medico Remedies Before You Invest

Before deciding whether Medico Remedies deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.

1. Open the Univest Screener and search for Medico Remedies to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
2. Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
3. Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
4. Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.

Conclusion

Medico Remedies earns a place in the best stock in its sector conversation on the strength of a 17.38% ROE and a P/E of 13.00x against a 51.55x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.

Is Medico Remedies the best stock in its sector?

Ans. Medico Remedies has a 17.38% ROE and trades at 13.00x P/E against a 51.55x Industry P/E, and compares above the peer average ROE of 11.20% in this article’s named comparison, so the answer depends on what an investor is prioritising.

What is the current share price of Medico Remedies?

Ans. Medico Remedies was trading at Rs 22.06 on the NSE as of 01 October 2026, within its 52-week range of Rs 20.47 to Rs 56.88.

What sector does Medico Remedies belong to?

Ans. Medico Remedies is classified under the Healthcare sector on Univest.

How does Medico Remedies compare to its sector peers on P/E?

Ans. Medico Remedies’s P/E of 13.00x is below the 19.28x average of the 2 named peers compared in this article.

What is Medico Remedies’s return on equity?

Ans. Medico Remedies reported a return on equity of 17.38%, which is above the 11.20% average of its named peers in this comparison.

Should I invest in Medico Remedies based on its sector position?

Ans. Medico Remedies’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.

{“@context”: “https://schema.org”, “@type”: “FAQPage”, “mainEntity”: [{“@type”: “Question”, “name”: “Is Medico Remedies the best stock in its sector?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Medico Remedies has a 17.38% ROE and trades at 13.00x P/E against a 51.55x Industry P/E, and compares above the peer average ROE of 11.20% in this article’s named comparison, so the answer depends on what an investor is prioritising.”}}, {“@type”: “Question”, “name”: “What is the current share price of Medico Remedies?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Medico Remedies was trading at Rs 22.06 on the NSE as of 01 October 2026, within its 52-week range of Rs 20.47 to Rs 56.88.”}}, {“@type”: “Question”, “name”: “What sector does Medico Remedies belong to?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Medico Remedies is classified under the Healthcare sector on Univest.”}}, {“@type”: “Question”, “name”: “How does Medico Remedies compare to its sector peers on P/E?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Medico Remedies’s P/E of 13.00x is below the 19.28x average of the 2 named peers compared in this article.”}}, {“@type”: “Question”, “name”: “What is Medico Remedies’s return on equity?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Medico Remedies reported a return on equity of 17.38%, which is above the 11.20% average of its named peers in this comparison.”}}, {“@type”: “Question”, “name”: “Should I invest in Medico Remedies based on its sector position?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Medico Remedies’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.”}}]}